摘要
肝癌术后高复发率是目前制约肝癌患者长期生存的主要问题。目前预防肝癌术后复发的方法较多,但各个方法的适应证、临床疗效和相互作用尚未形成共识。针对这一问题,本文对肝癌根治性切除术后辅助性治疗方案进行了综述,以对此类患者的治疗提供参考。
The high incidence of postoperative recurrence of hepatocellular carcinoma ( HCC) is a most difficult obstacle for improving the prognosis of patients.Several adjuvant modalities have been developed to prevent recurrence in patients after surgery; nevertheless , there is no consensus regarding the standardized adjuvant therapy in terms of indications , clinical efficacy and interactions.In this article we review the currently available evidence in the medical literature on adjuvant therapy in HCC after radical resection.
作者
徐建波
许刚
张建淮
黄明德
祁付珍
Xu Jianbo Xu Gang Zhang Jianhuai Huang Mingde Qi Fuzhen(Department of General Surgery, Huai' an First People's Hospital, Nanjing Medical University, Huai'an 223300, Jiangsu, Chin)
出处
《中华全科医师杂志》
2017年第1期72-75,共4页
Chinese Journal of General Practitioners
基金
江苏省淮安市社会发展基金(HAS2014011)
关键词
癌
肝细胞
肿瘤辅助疗法
Neoadjuvant therapy
Carcinoma,hepatocellular